Shattering the Amyloid Illusion: The Microbial Enigma of Alzheimer’s Disease Pathogenesis—From Gut Microbiota and Viruses to Brain Biofilms
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(1), P. 90 - 90
Published: Jan. 5, 2025
For
decades,
Alzheimer's
Disease
(AD)
research
has
focused
on
the
amyloid
cascade
hypothesis,
which
identifies
amyloid-beta
(Aβ)
as
primary
driver
of
disease.
However,
consistent
failure
Aβ-targeted
therapies
to
demonstrate
efficacy,
coupled
with
significant
safety
concerns,
underscores
need
rethink
our
approach
AD
treatment.
Emerging
evidence
points
microbial
infections
environmental
factors
in
pathoetiology.
Although
a
definitive
causal
link
remains
unestablished,
collective
is
compelling.
This
review
explores
unconventional
perspectives
and
emerging
paradigms
regarding
involvement
pathogenesis,
emphasizing
gut-brain
axis,
brain
biofilms,
oral
microbiome,
viral
infections.
Transgenic
mouse
models
show
that
gut
microbiota
dysregulation
precedes
Aβ
accumulation,
signaling
pathways.
Viral
like
Herpes
Simplex
Virus
Type
1
(HSV-1)
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2)
may
lead
by
modulating
host
processes
immune
system.
peptide's
antimicrobial
function
response
infection
might
inadvertently
promote
AD.
We
discuss
potential
microbiome-based
promising
strategies
for
managing
potentially
preventing
progression.
Fecal
transplantation
(FMT)
restores
balance,
reduces
improves
cognition
preclinical
models.
Probiotics
prebiotics
reduce
neuroinflammation
plaques,
while
antiviral
targeting
HSV-1
vaccines
shingles
vaccine
mitigate
pathology.
Developing
effective
treatments
requires
standardized
methods
identify
measure
patients,
enabling
personalized
address
individual
contributions
pathogenesis.
Further
needed
clarify
interactions
between
microbes
Aβ,
explore
bacterial
interplay,
understand
their
broader
effects
translate
these
insights
into
clinical
interventions.
Language: Английский
Association of Methyl Donor Nutrients’ Dietary Intake and Cognitive Impairment in the Elderly Based on the Intestinal Microbiome
Qianqian Chen,
No information about this author
Rui Fan,
No information about this author
Lixia Song
No information about this author
et al.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(13), P. 2061 - 2061
Published: June 28, 2024
Globally,
cognitive
impairment
(CI)
is
the
leading
cause
of
disability
and
dependency
among
elderly,
presenting
a
significant
public
health
concern.
However,
there
currently
deficiency
in
pharmacological
interventions
that
can
effectively
cure
or
significantly
reverse
progression
impairment.
Methyl
donor
nutrients
(MDNs),
including
folic
acid,
choline,
vitamin
B12,
have
been
identified
as
potential
enhancers
function.
Nevertheless,
remains
dearth
comprehensive
research
investigating
connection
between
dietary
intake
MDNs
CI.
In
our
study,
we
comprehensively
assessed
relationship
MDNs’
CI
older
adults,
utilizing
16S
rRNA
gene
sequencing
to
investigate
underlying
mechanisms.
The
results
showed
an
obvious
difference
methyl-donor
nutritional
quality
index
(MNQI)
dementia
(D)
group
dementia-free
(DF)
group.
Specifically,
was
lower
MNQI
D
than
DF
For
gut
microbiome,
beta
diversity
flora
exhibited
higher
levels
high
(HQ)
opposed
low
(LQ)
group,
comparison
Subsequently,
performed
correlation
analysis
examine
relative
abundance
microbiota,
MDNs,
Montreal
Cognitive
Assessment
(MoCA)
scores,
ultimately
identifying
ten
genera
with
regulatory
functions.
Additionally,
KEGG
pathway
analyses
suggested
one-carbon
metabolism,
chronic
inflammation,
DNA
synthesis
potentially
serve
pathways
through
which
may
be
promising
for
influencing
These
implied
might
enhance
function
regulation
microbiota
homeostasis.
This
study
offers
recommendations
prevention
management
elderly.
Language: Английский
Identification of critical genes and drug repurposing targets in entorhinal cortex of Alzheimer’s disease
Neurogenetics,
Journal Year:
2025,
Volume and Issue:
26(1)
Published: Feb. 10, 2025
Language: Английский
SFRP1 upregulation causes hippocampal synaptic dysfunction and memory impairment
Guadalupe Pereyra,
No information about this author
María Inés Mateo,
No information about this author
Pablo Miaja
No information about this author
et al.
Cell Reports,
Journal Year:
2025,
Volume and Issue:
44(4), P. 115535 - 115535
Published: April 1, 2025
Impaired
neuronal
and
synaptic
function
are
hallmarks
of
early
Alzheimer's
disease
(AD),
preceding
other
neuropathological
traits
cognitive
decline.
We
previously
showed
that
SFRP1,
a
glial-derived
protein
elevated
in
AD
brains
from
preclinical
stages,
contributes
to
progression,
implicating
glial
factors
pathogenesis.
Here,
we
generate
analyze
transgenic
mice
overexpressing
astrocytic
SFRP1.
SFRP1
accumulation
causes
dendritic
defects
adult
mice,
followed
by
impaired
long-term
potentiation
decline,
evident
only
when
the
animals
age,
thereby
mimicking
AD's
structural-functional
temporal
distinction.
This
phenotype
correlates
with
proteomic
changes,
including
increased
structural
proteins
like
neurexin,
which
localizes
close
proximity
cultured
hippocampal
neurons.
conclude
excessive
hinders
turnover,
reducing
plasticity-a
mechanism
may
underlie
synaptopathy
observed
prodromal
patients.
Language: Английский
Resistance Exercise Training as a New Trend in Alzheimer’s Disease Research: From Molecular Mechanisms to Prevention
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(13), P. 7084 - 7084
Published: June 27, 2024
Alzheimer's
disease
is
a
pathology
characterized
by
the
progressive
loss
of
neuronal
connections,
which
leads
to
gray
matter
atrophy
in
brain.
most
prevalent
type
dementia
and
has
been
classified
into
two
types,
early
onset,
associated
with
genetic
factors,
late
environmental
factors.
One
greatest
challenges
regarding
high
economic
cost
involved,
why
number
studies
aimed
at
prevention
treatment
have
increased.
possible
approach
use
resistance
exercise
training,
given
that
it
shown
neuroprotective
effects
disease,
such
as
increasing
cortical
hippocampal
volume,
improving
neuroplasticity,
promoting
cognitive
function
throughout
life
cycle.
However,
how
training
specifically
prevents
or
ameliorates
not
fully
characterized.
Therefore,
aim
this
review
was
identify
molecular
basis
could
prevent
treat
disease.
Language: Английский
One Path, Two Solutions: Network-Based Analysis Identifies Targetable Pathways for the Treatment of Comorbid Type II Diabetes and Neuropsychiatric Disorders
Computational and Structural Biotechnology Journal,
Journal Year:
2024,
Volume and Issue:
23, P. 3610 - 3624
Published: Oct. 10, 2024
Language: Английский
Integration of genomic and transcriptomic layers in RNA‐Seq data leads to protein interaction modules with improved Alzheimer's disease associations
European Journal of Neuroscience,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 12, 2024
Alzheimer's
disease
(AD)
is
the
most
common
neurodegenerative
disease,
and
it
currently
untreatable.
RNA
sequencing
(RNA-Seq)
commonly
used
in
literature
to
identify
AD-associated
molecular
mechanisms
by
analysing
changes
gene
expression.
RNA-Seq
data
can
also
be
detect
genomic
variants,
enabling
identification
of
genes
with
a
higher
load
deleterious
variants
patients
compared
controls.
Here,
we
analysed
AD
datasets
obtain
differentially
expressed
pathogenic
AD,
combined
them
single
list.
We
mapped
these
on
human
protein-protein
interaction
network
discover
subnetworks
perturbed
AD.
Our
results
show
that
utilizing
pathogenicity
information
from
positively
contributes
disclosure
AD-related
mechanisms.
Moreover,
dividing
discovered
into
highly
connected
modules
reveals
clearer
picture
altered
pathways
that,
otherwise,
would
not
captured.
Repeating
whole
pipeline
metabolic
led
confirming
positive
contribution
enabled
more
detailed
Language: Английский